Astrocyte elevated gene-1 overexpression in histologically favorable Wilms tumor is related to poor prognosis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Pediatric Urology

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpurol.2013.09.010PMID 24119914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gain of 1q is associated with inferior event‐free and overall survival in patients with favorable histology Wilms tumor: A report from the Children's Oncology Group

  2013cited by this paper
• B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.

  2013cited by this paper
• Outcomes of Wilms’ Tumor in Eastern China: 10 Years of Experience at a Single Center

  2012cited by this paper
• Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer

  2011cited by this paper
• Clinical Significance of Astrocyte Elevated Gene-1 Expression in Human Epithelial Ovarian Carcinoma

  2011cited by this paper
• Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma

  2011cited by this paper
• Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosis

  2011cited by this paper
• Apoptotic protein expression in favorable-histology Wilms tumor correlates with tumor recurrence

  2011cited by this paper
• Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion.

  2010cited by this paper
• Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression.

  2010cited by this paper
• Astrocyte Elevated Gene-1: A Novel Target for Human Glioma Therapy

  2010cited by this paper
• Prognostic significance of AEG-1 expression in colorectal carcinoma

  2010cited by this paper
• Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression.

  2009cited by this paper
• Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis.

  2009cited by this paper
• Over‐expression of AEG‐1 significantly associates with tumour aggressiveness and poor prognosis in human non‐small cell lung cancer

  2009cited by this paper
• Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1

  2009cited by this paper
• Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis

  2009cited by this paper
• Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma

  2009cited by this paper
• Astrocyte Elevated Gene-1 is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival

  2008cited by this paper
• Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling

  2008cited by this paper
• Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1.

  2008cited by this paper
• Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour

  2007cited by this paper
• Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity

  2007cited by this paper
• Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration.

  2007cited by this paper
• Activation of the Nuclear Factor κB Pathway by Astrocyte Elevated Gene-1: Implications for Tumor Progression and Metastasis

  2006cited by this paper
• Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse

  2006cited by this paper
• Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc

  2006cited by this paper
• The challenge of nephroblastoma in a developing country.

  2006cited by this paper
• Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis.

  2006cited by this paper
• Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.

  2005cited by this paper
• Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment.

  2003cited by this paper
• p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease.

  2002cited by this paper
• Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH

  2002cited by this paper
• Chromosome 1q expression profiling and relapse in Wilms' tumour.

  2002cited by this paper
• Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors.

  2001cited by this paper
• Wilms' tumor. Overview of National Wilms' Tumor Study Group results.

  2000cited by this paper
• Epidemiologic features of Wilms tumor.

  1995cited by this paper
• Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.

  1994cited by this paper

• Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer.

  2022cites this paper
• A long non-coding RNAs expression signature to improve prognostic prediction of Wilms tumor in children

  2021cites this paper
• Clinical significance of tumoral PD-L1 expression in Wilms tumors.

  2021cites this paper
• TAF2: A potential oncogene for hepatocellular carcinoma

  2017cites this paper
• Biomarkers for Wilms Tumor: A Systematic Review.

  2016cites this paper
• Metadherin is required for the proliferation, migration, and invasion of esophageal squamous cell carcinoma and its meta-analysis.

  2015cites this paper